Recombinant HTLV-1 Active p24 Protein (aa 314-344) (VAng-Lsx0318)
HTLV type 1 Active p24 (aa 314-344), recombinant protein from E. coli.
Target
Human T-lymphotropic Virus
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
50mM Sodium phosphate, 1mM DTT, 1mM EDTA, pH 6.
Purity
> 95 % pure by SDS-PAGE.
Introduction
The human T-lymphotropic virus (HTLV), is a group of human retroviruses that are known to cause a type of cancer called adult T-cell leukemia/lymphoma and a demyelinating disease called HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). Studies show that HTLV belongs to a bigger family of primate T-lymphotropic viruses, also called as PTLVs. There are four members in this virus group have been found, including human T-lymphotropic virus type I (HTLV-1), human T-lymphotropic virus type II (HTLV-2), human T-lymphotropic virus type III (HTLV-3) and human T-lymphotropic virus type IV (HTLV-4).
Alternative Names
CA; Capsid protein p24; gag polyprotein; Major core protein p24; p24; HTLV I p24
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.